Mytrex F en es it fr

Mytrex F Brand names, Mytrex F Analogs

Mytrex F Brand Names Mixture

  • No information avaliable

Mytrex F Chemical_Formula


Mytrex F RX_link

Mytrex F fda sheet

Mytrex_F FDA

Mytrex F msds (material safety sheet)

Mytrex_F MSDS

Mytrex F Synthesis Reference

No information avaliable

Mytrex F Molecular Weight

926.09 g/mol

Mytrex F Melting Point


Mytrex F H2O Solubility

360 mg/L

Mytrex F State


Mytrex F LogP


Mytrex F Dosage Forms

Cream; Drops; Liquid; Ointment; Suspension; Tablet

Mytrex F Indication

For treatment of cutaneous or mucocutaneous mycotic infections caused by Candida species

Mytrex F Pharmacology

Nystatin is an antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi, including Candida albicans, C. parapsilosis, C. tropicalis, C. guilliermondi, C. pseudotropicalis, C. krusei, Torulopsis glabrata, Tricophyton rubrum, T. mentagrophytes. Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing levels of nystatin, Candida albicans does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However, other species of Candida (C. tropicalis, C. guilliermondi, C. krusei, and C. stellatoides) become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.

Mytrex F Absorption

Nystatin is not absorbed from intact skin or mucous membrane

Mytrex F side effects and Toxicity

No information avaliable

Mytrex F Patient Information

No information avaliable

Mytrex F Organisms Affected